Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Konstantina Tsechilidou
Observed name:
K. Tsechilidou
Institution:
European Organisation for Research and Treatment of Cancer
Observed institutions:
European Organisation for Research and Treatment of Cancer,
European Organisation for Research and Treatment of Cancer
ORCID:
0009-0008-7664-4685
Observed ORCID:
0009-0008-7664-4685
OpenAlex ID:
A5092083408
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
2025
·
R. Galot
, C. Le Tourneau
, et al.
·
ESMO Open
·
11
Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM)
2026
·
Rachel Galot
, Christophe Le Tourneau
, et al.
·
European Journal of Cancer
Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM).
2025
·
Rachel Galot
, Christophe Le Tourneau
, et al.
·
Journal of Clinical Oncology
PDF
Afatinib in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) harboring alterations in the HER pathway: Results of the B1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
2023
·
Rachel Galot
, Christophe Le Tourneau
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
4
Citation count:
11
H-index:
1
I10-index:
1
Year
Topic
Type